Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Pediatrics & Neonatal Care Volume 7 (2021), Article ID 7:IJPNC-174, 5 pages
https://doi.org/10.15344/2455-2364/2021/174
Original Reports
Institutionalising New-born Screening for Sickle Cell Disease at the Federal Medical Centre, Asaba, Nigeria

Ezinne Onyeka Okite, Clifford Okike, Berti Ezeonwu, Kayode Adeniran, Uche Chimah, Hyginus Opara, Emeka Abonyi and Angela Okolo*

The Department of Pediatrics, Federal Medical Center, Asaba, Delta State, Nigeria
Prof. Angela Okolo, The Department of Pediatrics, Federal Medical Center, Asaba, Delta State, Nigeria, Tel: 2348023346693; E-mail: aneneolisa@gmail.com
22 January 2021; 25 February 2021; 27 February 2021
Okite EO, Okike C, Ezeonwu B, Adeniran K, Chimah U, et al. (2021) Institutionalising New-born Screening for Sickle Cell Disease at the Federal Medical Centre, Asaba, Nigeria. Int J Pediatr Neonat Care 7: 174.doi: https://doi.org/10.15344/2455-2364/2021/174
© 2021 Okite et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Diallo D, Tchernia G (2002) Sickle cell disease in Africa. Curr Opin Hematol 9: 111-116. [CrossRef] [Google Scholar] [PubMed]
  2. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, et al. (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381: 142-151. [CrossRef] [Google Scholar] [PubMed]
  3. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN, et al. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med 10: e1001484. [CrossRef] [Google Scholar] [PubMed]
  4. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, et al. (2000) Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess. [Google Scholar] [PubMed]
  5. Odunvbun ME, Okolo AA, Rahimy CM (2008) Newborn screening for sickle cell disease in a Nigerian hospital. Public Health 122: 1111-1116. [CrossRef] [Google Scholar] [PubMed]
  6. Grosse SD, Olney RS, Baily MA (2005) The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique. Appl Health Econ Health Policy 4: 239-247. [CrossRef] [Google Scholar] [PubMed]
  7. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B, et al. (1988) Newborn screening for sickle cell disease: effect on mortality. Pediatrics 81: 749. [Google Scholar] [PubMed]
  8. WHO (2010) Sickle-cell disease: A strategy for the WHO African region.
  9. Tshilolo L, Kafando E, Sawadogo M, Cotton F, Vertongen F, et al. (2008) Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health 122: 933. [CrossRef] [Google Scholar] [PubMed]
  10. Ansong D, Akoto AO, Ocloo D, Ohene-Frempong K (2013) Sickle cell disease: management options and challenges in developing countries. Mediterr J Hematol Infect Dis 5: e2013062. [CrossRef] [Google Scholar] [PubMed]
  11. Odame I (2014) Perspective: we need a global solution. Nature 515: S10. [CrossRef] [Google Scholar] [PubMed]
  12. Bailey DB, Gehtland LM, Megan AMA, Peay H, Raspa M, et al. (2019) Translational science at the intersection of public health and newborn screening. BMC Pediatrics.
  13. Knight-Madden J, Lee K, Elana G, Elenga N, Marcheco-Teruel B, et al. (2019) Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence. Int J Neonatal Screen 5: 5. [CrossRef] [Google Scholar] [PubMed]
  14. Hsu L, Nnodu O, Brown B, Tluway F, King S, et al. (2018) White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa. J Trop Dis Public Health 6: 260. [CrossRef] [Google Scholar] [PubMed]
  15. Booth C, Inusa B, Obaro S (2010) Infection in sickle cell disease: A Review. Int J Infect Dis 14: e2-e12. [CrossRef] [Google Scholar] [PubMed]
  16. Rogers ZR, Wang WC, Luo Z, Iyer RV, Shalaby-Rana E, et al. (2011) Bio markers of splenic function in infants with sickle cell anemia: baseline data from the Baby HUG Trial. Blood 117: 2614-2617. [CrossRef] [PubMed]
  17. O’Brien RT, McLntosh S, Aspens GT, Pearson HA (1976) Prospective study of sickle cell anaemia in infancy. J Pediatr 89:205-210. [CrossRef] [Google Scholar] [PubMed]
  18. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, et al. (1986) Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med 314: 1593-1599. [CrossRef] [Google Scholar] [PubMed]
  19. Wastnedge E, Waters D, Patel S, Morrison K, Yi Goh M, et al. (2018) The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis. J Glob Health 8: 021103. [CrossRef] [Google Scholar] [PubMed]
  20. Nair SB (2018) Potential Pithfalls in Using HPLC and its Interpretation in Diagnosing HbS. J Rare Dis Res Treat 3: 9-12. [Google Scholar]
  21. Instruction Manual HPLC machine: Variant NBS Sickle cell Program. Bio-Rad Laboratory. Ref 250-3000.
  22. Nankanja R, Kadhumbula S, Tagoola A, Geisberg M, Serrao E, et al. (2019) HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda. Am J Hematol 94: E164-E166. [CrossRef] [Google Scholar] [PubMed]
  23. Hemoglobinopathies: Current Practices for Screening, Confirmation and Follow-up. Association of Public Health Laboratories. CDC edts.
  24. Lová D, Pešková K, Hermánková R, O’Driscoll R, Ješina P et al. (2019) Factors Influencing Parental Awareness about Newborn Screening. Int J Neonatal Screen 5: 35. [CrossRef] [Google Scholar] [PubMed]
  25. Fleming AF, Storey J, Molineaux L, Iroko EA, Attai ED, et al. (1979) Abnormal haemoglobin in the Sudan Savannah of Nigeria. Br J Haemato 73: 161-720.
  26. Kaine WN, Udeozo IO (1981) Incidence of sickle cell trait and anaemia in Ibo preschool children. Niger J Paediatr 8: 87-89. [Google Scholar]
  27. Umoh A, Abah G, Ekanem T, Essien E (2010) Haemoglobin Genotypes: A prevalence study and implications for reproductive health in Uyo, Nigeria. Nig J Med 19: 36-41. [CrossRef] [Google Scholar] [PubMed]
  28. Nigeria Demographic and Health Survey 2013. [View]
  29. Inusa BP, Daniel Y, Lawson JO, Dada J, Matthews CE, et al. (2015) Sickle cell disease screening in Northern Nigeria: The co-existence of Β- thalassemia inheritance. Pediat Therapeut 5: 262. [Google Scholar]
  30. Olatunji PO (2002) Sickle cell disease in developing countries: magnitude and challenges. Postgrad Doc Afr 25: 61-64.
  31. Meredith M, Victoria V, Charlotte C, Jenesse M (2006) Promoting Healthy Public Policy through Community Based Participatory Research: Ten Case Studies.
  32. Abhulimhen-Iyoha BI, Odunvbun ME, Okolo AA (2011) Haemoglobin electrophoresis in under-fives of Ekosodin community, Edo State, Nigeria. SMJ 14: 179-185. [Google Scholar]
  33. Abhulimhen-Iyoha BI, Isreal-Aina YT, Okolo AA (2013) Haemoglobin phenotypes of patients admitted to the children emergency room of the University of Benin Teaching Hospital, Benin City, Edo State, Nigeria. J Med Biomed Res 12: 11-16. [Google Scholar]
  34. Ohene-Frempong K, Oduro J, Tetteh H, Nkrumah F (2008) Screening newborns for sickle cell disease in Ghana. Pediatric 121: 120-121. [CrossRef] [Google Scholar]
  35. Olaniyi JA, Arinola GO (2009) Humoral immunity and haemoglobin F status in steady state adult Nigerian sickle cell disease patients with asymptomatic malaria. Turkish J Med Sci 39: 953-957. [Google Scholar]
  36. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B, et al. (1988) Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 81: 749-755. [Google Scholar] [PubMed]
  37. Sickle Cell Disease Guideline Panel. Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling.
  38. Gupta PK, Kumar H, Kumar S, Jaiprakash M (2009) Cation exchange high performance liquid chromatography for diagnosis of haemoglobinopathies. Med J Armed Forces India 65: 34-37. [CrossRef] [Google Scholar] [PubMed]
  39. Lehmann H, Nwokolo C (1959) The River Niger as a barrier to the spread eastward of haemoglobin C: a survey of haemoglobin in the Ibo. Nature 4675: 1957-1988. [CrossRef] [Google Scholar]
  40. Tshilolo L, Aissi LM, Lukasa D, Kinsiama C, Wembonyama S, et al. (2009) Neonatal screening for sickle cell anaemia in Democratic Republic of Congo: experience from a pioneer project on 31,204 newborns. J ClinPathol 621: 35-38. [CrossRef] [PubMed]
  41. Madji MS, Hanan H (2014) The ethnic distribution of sickle cell disease in Sudan. Pan Afr Med J 18: 13. [CrossRef] [Google Scholar] [PubMed]
  42. Rahimy M, Ahouignan G, Gangbo A, Akpona S, Zohoun I, et al. (1999) Newborn screening for sickle cell disease: five years’ experience in Cotonou. Arch Fr Pediatr 6: 343-344.
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.